GlassScriptPhysician profile
Jonathan Yazhari
NPI 1124769054
$4,051.77
in general payments reported to CMS, 2019-2025
16 companies · $4,052 in 2025
The $4,052 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,591 · Travel and Lodging: $1,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.28 |
| Travel and Lodging | $1,460.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,067.11 | 2025 | Portfolio, Monkey Rings |
| Integra Lifesciences Corporation | $690.69 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Arthrex, INC. | $484.90 | 2025 | |
| Stryker Corporation | $230.96 | 2025 | Infinity Adaptis, Inbone, N/A |
| Smith+Nephew, INC. | $201.56 | 2025 | Grafix Pl, Stravix Pl, Collagenase Santyl |
| Access Pro Medical, LLC | $185.35 | 2025 | Matriderm |
| Medline Industries LP | $166.12 | 2025 | |
| Polynovo North America LLC | $160.41 | 2025 | Novosorb Btm |
| Medshape, INC. | $147.53 | 2025 | Dynanail |
| Kerecis Limited | $144.10 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Conetic Solutions, INC. | $138.22 | 2025 | |
| Solventum Corporation | $133.42 | 2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Prevena |
| Southern Edge Orthopaedics, INC. | $121.47 | 2025 | |
| Treace Medical Concepts, INC. | $64.06 | 2025 | |
| Restor3d, INC. | $58.25 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $57.62 | 2025 | Puraply Wound Matrix, Apligraf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yazhari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.